# Addition of Acetaminophen in Standard PDA Management

> **NCT04026464** · PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Intravenous Ibuprofen
- **DRUG:** Intravenous Ibuprofen + Oral Acetaminophen

## Key facts

- **NCT ID:** NCT04026464
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04
- **Primary completion:** 2021-05-12
- **Final completion:** 2021-05-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to obtain funding to support this project
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026464, "Addition of Acetaminophen in Standard PDA Management". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04026464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*